Biomarkers of glucose-insulin homeostasis and incident type 2 diabetes and cardiovascular disease: results from the Vitamin D and Omega-3 trial is a research paper published in Cardiovascular Diabetology (2024). On theSindex it has a DataRank of 0.326. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0343
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: R01AT011729
NHLBI NIH HHS
Grant: K24 HL136852
NHLBI NIH HHS
Grant: K01 HL135342
NHLBI NIH HHS
Grant: R21 HL167173
National Institutes of Health
Grant: 5R01DK112940-02
Circulating plasma metabolites, diet, and risk of type 2 diabetes
National Institutes of Health
Grant: 5K24HL136852-03
Patient Centered Approaches to Preventing ASCVD Events
National Institutes of Health
Grant: 5R01AT011729-16
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
National Institutes of Health
Grant: 3R01HL134811-03S1
Reducing Inflammation for the Prevention of CVD: A Focus on Eicosanoid Pathways
National Institutes of Health
Grant: 3R01CA138962-10S1
The VITamin D and OmegA-3 TriaL (VITAL)
National Institutes of Health
Grant: 5R01HL160799-02
Targeting the Active Resolution of Inflammation for Cardiovascular Disease Prevention
Fields of Study
MeSH Terms
Keywords